This is the premier operating metric for investors to home in on after the closing bell.Over the past three years, nothing has garnered more attention on Wall Street than the rise of artificial intelligence (AI). Empowering software and systems with AI to make split-second decisions without the need for human oversight is a multitrillion-dollar global opportunity.While a long list of companies has benefited from the evolution of AI, Nvidia (NVDA 1.10%) currently finds itself atop the pedestal. It's added $4 ...

Financial Performance - Regeneron Pharmaceuticals reported adjusted earnings of $12.89 per share, a 12% increase year-over-year, surpassing the consensus estimate of $8.57 [1] - The company achieved sales of $3.68 billion, reflecting a 4% year-over-year growth, exceeding the consensus of $3.29 billion [1] Future Guidance - For 2025, Regeneron expects a GAAP gross margin of approximately 83%, slightly lower than the previous guidance of 83%-84% [2] - The adjusted gross margin is anticipated to be around 86%, compared to the prior guidance of 86%-87% [2] Market Reaction - Following the earnings announcement, Regeneron Pharmaceuticals shares increased by 0.9%, trading at $563.62 [3] Analyst Ratings and Price Targets - Guggenheim analyst Yatin Suneja maintained a Buy rating and raised the price target from $810 to $815 [5] - RBC Capital analyst Brian Abrahams maintained a Sector Perform rating and increased the price target from $688 to $695 [5] - Morgan Stanley analyst Matthew Harrison maintained an Overweight rating and raised the price target from $754 to $761 [5]

If you're just waiting for Nvidia's sales and earnings per share figures, you'll be missing out on the big picture. One of the most-anticipated days of the second quarter has arrived. Amid a flurry of economic data and President Donald Trump regularly changing his administration's tariff and trade policies, Wall Street's artificial intelligence (AI) darling Nvidia (NVDA 3.07%) is set to report its fiscal 2026 first-quarter operating results after the closing bell today (May 28). A lot of investors tend to f ...